The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
Article usage
Posted July 14, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (714)
- Anesthesia (208)
- Cardiovascular Medicine (2982)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12837)
- Forensic Medicine (12)
- Gastroenterology (837)
- Genetic and Genomic Medicine (4641)
- Geriatric Medicine (427)
- Health Economics (733)
- Health Informatics (2952)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (936)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4430)
- Nursing (238)
- Nutrition (653)
- Oncology (2305)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1204)
- Primary Care Research (506)
- Public and Global Health (7026)
- Radiology and Imaging (1556)
- Respiratory Medicine (925)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (493)
- Toxicology (60)
- Transplantation (213)
- Urology (185)